Cargando...

The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics – Is Personalized Therapy in Sight?

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide requiring therapy. Despite recent advances in catheter-based and surgical therapy, antiarrhythmic drugs (AAD) remain the mainstay of treatment for symptomatic AF. However, response in individual patients is highly var...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cardiovasc Pharmacol
Autor principal: Darbar, Dawood
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639470/
https://ncbi.nlm.nih.gov/pubmed/25970841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000280
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!